Another Biosimilar for a Common Breast Cancer Rx
The US Food and Drug Administration (FDA) has approved another biosimilar for a common breast cancer medication.
Company Under Fire for Illegal Screening Tool
Total Thermal Imaging, Inc., is in the hot seat for marketing and selling an unapproved product for detecting certain diseases.
A New Biosimilar for a Breast Cancer Rx
The US Food and Drug Administration (FDA) has approved the third Herceptin (trastuzumab) biosimilar to treat certain types of cancer.
New Device Guides Breast Cancer Biopsies
The US Food and Drug Administration (FDA) has approved a new device to guide lymph node biopsies in patients with breast cancer.
BRCA Mutations: Who Should Get Tested?
BRCA1 and BRCA2 gene mutations increase breast cancer risk. So how do you know if you have these gene mutations?
FDA Approves At-Home Cancer Risk Test
The US Food and Drug Administration (FDA) has approved a home DNA test that can provide limited information about cancer risk.
The Benefits of Exercise After Breast Cancer
Aerobic exercise and resistance training could help women who have survived breast cancer live longer, according to a new study.
Several New Medications Approved
As a new year begins, we celebrate the beginning of something new and exciting. This year, that includes several new medication approvals from the US Food and Drug Administration (FDA).
New Nonsurgical Breast Cancer Treatment Approved
The US Food and Drug Administration (FDA) has approved a new radiation therapy system to treat breast cancer.
Breast Cancer: Knowing Your Options
Some women with breast cancer may not feel completely informed about their treatment options, according to a new study.